Ru Yang
Direktor/Vorstandsmitglied bei SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD
Aktive Positionen von Ru Yang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD | Direktor/Vorstandsmitglied | 01.08.2021 | - |
| Independent Dir/Board Member | 01.08.2021 | - | |
Xiamen Zeesan Biotech Co., Ltd.
 Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Direktor/Vorstandsmitglied | 23.08.2021 | - |
| Independent Dir/Board Member | 23.08.2021 | - |
Karriereverlauf von Ru Yang
Ausbildung von Ru Yang
| Southwest University of Political & Law | Graduate Degree |
Statistik
International
| China | 4 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Graduate Degree | 1 |
Sektoral
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Xiamen Zeesan Biotech Co., Ltd.
Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Health Services |